Stocks / CRL
CRL stock forecast
CHARLES RIVER LABORATORIES INTERNATIONAL INC · Healthcare · Diagnostics & Research
Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.
CRL is not among the 20 largest holdings published for 2026 Q4. See the portfolio
CRL against the S&P 500
| Period | CRL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +11.1% | -4.7% |
| 3 months | +14.9% | -4.8% |
| Year to date | +67.1% | +7.9% |
| 1 year | +105.0% | +11.8% |
Total return, dividends included.
Key numbers
| Price | $333.25 |
| Market cap | 15.97 Billion |
| P/E (trailing 12 months) | 311.4 |
| P/S (trailing 12 months) | 4.0 |
| P/B (latest quarter) | 4.8 |
| Gross margin | 33.3% |
| Net profit margin | 1.0% |
| Return on equity | 1.3% |
| Beta | 1.3 |
As of November 4, 2026.
CRL and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| RVTY | REVVITY INC | 17.02 Billion | Underperform | RVTY vs CRL |
| DGX | QUEST DIAGNOSTICS INC | 28.57 Billion | Underperform | DGX vs CRL |
| LH | LABCORP HOLDINGS INC | 30.11 Billion | Underperform | LH vs CRL |
| ILMN | ILLUMINA INC | 31.75 Billion | Outperform | |
| MTD | METTLER TOLEDO INTERNATIONAL INC | 34.55 Billion | Greatly Underperform | |
| IQV | IQVIA HOLDINGS INC | 42.49 Billion | Underperform |
Questions
What does the Upfront Investment model say about CRL?
The model rates CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL) "Greatly Underperform" as of November 18, 2026, which means its medium-term return forecast is in the bottom fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the CRL rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is CRL in the Upfront Investment model portfolio?
CRL is not among the 20 largest holdings published for 2026 Q4.
The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.